Arrowstreet Capital’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146M Buy
2,093,256
+722,816
+53% +$40.1M 0.06% 262
2026
Q1
$58.4M Buy
1,370,440
+716,949
+110% +$28.9M 0.03% 451
2025
Q4
$24.5M Buy
653,491
+333,357
+104% +$11.2M 0.01% 681
2025
Q3
$9.46M Buy
320,134
+219,005
+217% +$5.09M 0.01% 973
2025
Q2
$2.39M Sell
101,129
-339,508
-77% -$7.08M ﹤0.01% 1388
2025
Q1
$7.97M Sell
440,637
-712,540
-62% -$14M 0.01% 876
2024
Q4
$19.6M Sell
1,153,177
-394,777
-26% -$6.83M 0.02% 613
2024
Q3
$22.7M Buy
1,547,954
+1,218,951
+370% +$15.3M 0.02% 512
2024
Q2
$3.74M Buy
+329,003
New +$3.59M ﹤0.01% 919

Other funds holding BTSG

Arrowstreet Capital's BTSG Position: Q2 2026 in Review

Arrowstreet Capital increased its BrightSpring Health Services (BTSG) stake by 53% in Q2 2026, buying an estimated $40.1M and bringing the position to 2,093,256 shares worth $146M. The position accounts for 0.06% of the portfolio, ranked #262.

Arrowstreet Capital first reported a position in BTSG in Q2 2024 and has held it in 9 quarters since. 422 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • Arrowstreet Capital held 2,093,256 shares of BrightSpring Health Services worth $146M as of Q2 2026.
  • Arrowstreet Capital bought 722,816 BrightSpring Health Services shares in Q2 2026, an estimated $40.1M.
  • BrightSpring Health Services made up 0.06% of Arrowstreet Capital's portfolio in Q2 2026, its #262 holding.
  • Arrowstreet Capital first reported a position in BrightSpring Health Services in Q2 2024 and has held it in 9 quarters since.
  • 422 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.